Skip to main content

Day: August 29, 2024

Photronics Reports Third Quarter Fiscal 2024 Results and Share Repurchase Authorization

BROOKFIELD, Conn., Aug. 29, 2024 (GLOBE NEWSWIRE) — Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, today reported financial results for its third quarter of fiscal year 2024 ended July 28, 2024. “Market softness in some segments during the quarter impacted photomask demand, reducing both IC and FPD revenue,” said Frank Lee, chief executive officer. “The photomask demand recovery that started to take shape early in the third quarter slowed during the period due to select regional and end-use customer order patterns. This was combined with broader customer focus on rising semiconductor channel inventory that limited chip design activity through the quarter. In response, we tuned our mix and sales strategy, allowing us to optimize margins despite lower demand. Megatrends such as AI, supply...

Continue reading

Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

CLUE is a Multi-center Trial to Identify how Often Nociscan’s AI Data Changes the Initial Treatment Plan for Patients With Chronic Low Back Pain Dr. Justin Kubeck Will Initiate CLUE in New Jersey at Ocean Pain and Spine in Toms River BROOMFIELD, CO, Aug. 29, 2024 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today the expansion of the multi-center CLUE Trial to New Jersey. Justin Kubeck, MD, orthopedic spine surgeon and founder of Ocean Pain and Spine in Toms River, NJ will join an expanding network of spine surgeons participating in CLUE to build a growing body of data supporting the real-world value...

Continue reading

Titan Machinery Inc. Announces Results for Fiscal Second Quarter Ended July 31, 2024

– Reiterates Recently Updated Fiscal 2025 Modeling Assumptions – WEST FARGO, N.D., Aug. 29, 2024 (GLOBE NEWSWIRE) — Titan Machinery Inc. (Nasdaq: TITN) (“Titan” or the “Company”), a leading network of full-service agricultural and construction equipment stores, today reported financial results for the fiscal second quarter ended July 31, 2024. “As previously announced, our second quarter results reflect the challenging market conditions that are impacting farmer sentiment and agriculture equipment sales,” commented Bryan Knutson, Titan Machinery’s President and Chief Executive Officer. “In response to these market dynamics, we have been executing on the strategies we outlined: actively managing our inventory levels with a focus on used equipment, implementing targeted...

Continue reading

Burlington Stores, Inc. Reports Second Quarter 2024 Earnings

Total sales growth of 13%; comparable store sales growth of 5% Net income was $74 million, and diluted EPS was $1.15 Excluding certain expenses associated with acquired BBBY leases:Adjusted EBIT margin increased 160 basis points Adjusted EPS increased 98% to $1.24 Adjusted EPS guidance for FY24 raised to $7.66-$7.96BURLINGTON, N.J., Aug. 29, 2024 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL), a nationally recognized off-price retailer of high-quality, branded apparel, footwear, accessories, and merchandise for the home at everyday low prices, today announced its results for the second quarter ended August 3, 2024. Michael O’Sullivan, CEO, stated, “We are pleased with our results from the second quarter. Comparable store sales increased 5%, while total sales increased 13%. Both of these metrics were well ahead...

Continue reading

Atour Lifestyle Holdings Limited Reports Second Quarter of 2024 Unaudited Financial Results

A total of 1,412 hotels, or 161,686 hotel rooms, in operation as of June 30, 2024. Net revenues for the second quarter of 2024 increased by 64.5% year-over-year to RMB1,797 million (US$247 million), compared with RMB1,093 million for the same period of 2023. Net income for the second quarter of 2024 increased by 27.1% year-over-year to RMB304 million (US$42 million), compared with RMB239 million for the same period of 2023. Adjusted net income (non-GAAP)1 for the second quarter of 2024 increased by 31.6% year-over-year to RMB328 million (US$45 million), compared with RMB249 million for the same period of 2023. EBITDA (non-GAAP)2 for the second quarter of 2024 increased by 25.3% year-over-year to RMB419 million (US$58 million), compared with RMB334 million for the same period of 2023. Adjusted EBITDA (non-GAAP)3 for the second quarter...

Continue reading

Atour Lifestyle Holdings Limited Announces 3-Year Annual Dividend Policy

SHANGHAI, Aug. 29, 2024 (GLOBE NEWSWIRE) — Atour Lifestyle Holdings Limited (“Atour” or the “Company”) (NASDAQ: ATAT), a leading hospitality and lifestyle company in China, today announced that, as a part of the Company’s ongoing efforts to enhance shareholder value, its Board of Directors (the “Board”) has approved a three-year annual dividend policy (the “Annual Dividend Policy”). Under the Annual Dividend Policy, the Company plans to declare and distribute dividends with an aggregate amount of no less than 50% of its net income for the preceding financial year in each of the three financial years commencing this year. The exact dividend amount will be determined at the Board’s discretion, based on its assessment of the Company’s actual and projected results of operations, financial and cash position, capital requirements and...

Continue reading

IN8bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NEW YORK, Aug. 29, 2024 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today announced that William Ho, CEO and co-founder, will be presenting at the: H.C. Wainwright 26th Annual Global Investment ConferenceFormat Fireside ChatDate/Time Monday, September 9, 2024, at 2:30 p.m. ET. A live webcast and replay will be available under “Events and Presentations” in the News & Presentations section of the IN8bio website at https://investors.in8bio.com. About IN8bio IN8bio is a clinical-stage biopharmaceutical company developing gamma-delta T cell-based immunotherapies for cancer patients. Gamma-delta T cells are a specialized population of T cells that possess unique properties, including the ability to differentiate...

Continue reading

Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability

VANCOUVER, British Columbia, Aug. 29, 2024 (GLOBE NEWSWIRE) — AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) reports on its mid-year results for 2024 demonstrating the Company’s continued success in maintaining strong growth in revenues while achieving net profitability. In the six months ended June 30, 2024 revenues grew by 84% year-over-year, topping $2,169,513 with gross profit increasing 94% equalling $855,566. This was supported by Q2 2024 revenue increasing 91% against the same period in 2023 to $1,045,206, with gross profit topping $370,775, a 62% gain. This success led the Company to recording a net profit of $222,559 and posting a net increase in cash of $279,039. “Our success comes from great partners, an incredible team and a shared mission by all that believes everyone deserves better access...

Continue reading

Duluth Holdings Inc. Announces Second Quarter 2024 Financial Results

Year-over-year net sales growth of 1.8% to $141.6 million Benefiting from our product and sourcing initiatives, gross margin expands 90 basis points to 52.3% Strong financial position with no debt and approximately $210 million of liquidity Reaffirmed Fiscal 2024 outlook excluding restructuring expense and sales tax expense accrual MOUNT HOREB, Wis., Aug. 29, 2024 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or the “Company”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s workwear, casual wear, outdoor apparel and accessories, today announced its financial results for the fiscal second quarter ended July 28, 2024. Summary of the Second Quarter Ended July 28, 2024Net sales of 141.6 million increased 1.8% compared to the prior year second quarter Net loss of $3.7 million and adjusted...

Continue reading

36Kr Holdings Inc. to Report 2024 First Half Financial Results on Tuesday, September 3, 2024

BEIJING, Aug. 29, 2024 (GLOBE NEWSWIRE) — 36Kr Holdings Inc. (“36Kr” or the “Company”) (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants in China, today announced that it will report its 2024 first half unaudited financial results, on Tuesday, September 3, 2024, before the open of U.S. markets. The Company’s management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on September 3, 2024 (8:00 p.m. Beijing/Hong Kong Time on September 3, 2024). For participants who wish to join the call by phone, please access the link provided below to complete the pre-registration and dial in 5 minutes prior to the scheduled call start time. Upon registration, each participant will receive dial-in details to join the conference call.Event Title: 36Kr Holdings Inc. 2024...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.